These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7012050)

  • 21. Dapsone-induced methemoglobinemia in leprosy patients.
    Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770
    [No Abstract]   [Full Text] [Related]  

  • 22. Sulfapyridine and sulfones decrease glycosaminoglycans viscosity in dermatitis herpetiformis, ulcerative colitis, and pyoderma gangrenosum.
    Stone OJ
    Med Hypotheses; 1990 Feb; 31(2):99-103. PubMed ID: 2182989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The haemolytic action of dapsone: the effect on red-cell glycolysis.
    Rasbridge MR; Scott GL
    Br J Haematol; 1973 Feb; 24(2):169-81. PubMed ID: 4713624
    [No Abstract]   [Full Text] [Related]  

  • 24. [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
    Machet L; Callens A; Mercier E; Gargot S; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1996; 123(5):328-30. PubMed ID: 8761086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methemoglobinemia associated with the ingestion of Diasone.
    Fisher I; Orkin M
    Arch Dermatol; 1965 Sep; 92(3):327. PubMed ID: 11851261
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: Bullous pemphigoid.
    Stone SP
    Arch Dermatol; 1974 Nov; 110(5):812. PubMed ID: 4419851
    [No Abstract]   [Full Text] [Related]  

  • 27. Severe dapsone hypersensitivity syndrome.
    Sener O; Doganci L; Safali M; Besirbellioglu B; Bulucu F; Pahsa A
    J Investig Allergol Clin Immunol; 2006; 16(4):268-70. PubMed ID: 16889287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic use of dapsone in dermatitis herpetiformis (Duhring) and in certain inflammatory skin diseases].
    Révész K; Schneider I
    Orv Hetil; 1995 Jan; 136(2):59-62. PubMed ID: 7862431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible dapsone-induced peripheral neuropathy in dermatitis herpetiformis.
    du Vivier A; Fowler T
    Proc R Soc Med; 1974 Jun; 67(6 Pt 1):439-40. PubMed ID: 4369028
    [No Abstract]   [Full Text] [Related]  

  • 30. "Sulfoxone (Diasone) sodium for dermatitis herpetiformis" by Cornbleet, December 1951. Commentary: Sulfoxone (Diasone) in the treatment of dermatitis herpetiformis.
    Katz SI
    Arch Dermatol; 1982 Oct; 118(10):805-12. PubMed ID: 6753759
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone.
    Molinelli E; Paolinelli M; Campanati A; Brisigotti V; Offidani A
    Expert Opin Drug Metab Toxicol; 2019 May; 15(5):367-379. PubMed ID: 30943794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy of leprosy.
    Shepard CC
    Annu Rev Pharmacol; 1969; 9():37-50. PubMed ID: 4892433
    [No Abstract]   [Full Text] [Related]  

  • 33. [What do we know today about diaminodiphenylsulfone?].
    Golusin Z; Poljacki M; Preveden R; Stojanović S; Rajić N
    Med Pregl; 2000; 53(7-8):369-72. PubMed ID: 11214480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methemoglobinemia from dapsone therapy for a suspected brown spider bite.
    Iserson KV
    J Emerg Med; 1985; 3(4):285-8. PubMed ID: 4093581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient compliance with dapsone administration in leprosy.
    Huikeshoven H
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):228-58. PubMed ID: 7024150
    [No Abstract]   [Full Text] [Related]  

  • 36. Case records of the Massachusetts General Hospital: Case 7-2011: a 52-year-old man with upper respiratory symptoms and low oxygen saturation levels.
    Pallais JC; Mackool BT; Pitman MB
    N Engl J Med; 2011 Mar; 364(10):957-66. PubMed ID: 21388314
    [No Abstract]   [Full Text] [Related]  

  • 37. Fatal hemolysis from mafenide treatment of burns in a patient with glucose-6-phosphate dehydrogenase deficiency. Case report.
    Marsicano AR; Hutton JJ; Bryant WM
    Plast Reconstr Surg; 1973 Aug; 52(2):197-9. PubMed ID: 4722683
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of synthetic ACTH in the therapy of dermatologic diseases].
    Schuppli R
    Dermatologica; 1969; 139(4):243-53. PubMed ID: 4392894
    [No Abstract]   [Full Text] [Related]  

  • 39. Dapsone-induced methemoglobinemia: an anesthetic risk.
    Szeremeta W; Dohar JE
    Int J Pediatr Otorhinolaryngol; 1995 Aug; 33(1):75-80. PubMed ID: 7558644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse reactions to dapsone.
    Lancet; 1981 Jul; 2(8239):184-5. PubMed ID: 6114249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.